跳至主要内容
临床试验/IRCT201112178428N1
IRCT201112178428N1已完成3 期

A comparison of the effectiveness, side effects and acceptability of Plavix and Osivix as anti platelet tablets in patients undergoing Coronary artery by pass.

Research Deputy of Hamadan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 75 years(—)
性别
All

入选标准

  • All patients undergoing open heart surgery
  • Exclusion criteria: 1- Patients with a prior events of acute coronary syndrome, 2- Hepatic insufficiency, 3- History of significant bleeding disorder,4- Those already taking anti-platelet and/or anticoagulant therapy, 5- Age less than 20 and over than 75.

排除标准

  • 未提供

研究者

发起方
Research Deputy of Hamadan University of Medical Sciences

相似试验